Scarica l'app Stockscreener
18.47
3.88%
0.69
Dopo l'orario di chiusura:
18.47
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NEO Giù?
Forum
Previsione
Frazionamento azionario
Neogenomics Inc Borsa (NEO) Ultime notizie
NeoGenomics, Inc. (NEO) Stock Forecasts - Yahoo Finance
Zacks Research Downgrades NeoGenomics (NASDAQ:NEO) to Hold - MarketBeat
NeoGenomics stock trades at EUR 17.04 after Q2 EPS beat - AD HOC NEWS
NeoGenomics, Inc. (NEO) stock price, news, quote and history - au.finance.yahoo.com
Is NeoGenomics Inc (NEO) Overvalued After 6.5% Rally? GF Value S - GuruFocus
NeoGenomics (NASDAQ:NEO) Trading 4.8% HigherHere's Why - MarketBeat
NeoGenomics, Inc. (NEO) Stock forecasts - Yahoo Finance Singapore
NeoGenomics stock falls 2.81 percent after Q2 revenue beat - AD HOC NEWS
Precision Oncology Expansion Could Be A Game Changer For NeoGenomics Stock - Simply Wall Street
Liquidity Mapping Around (NEO) Price Events - Stock Traders Daily
NeoGenomics, Inc. (NEO) Stock Analysis: Strong Buy Ratings Amid 11.2% Revenue Growth - DirectorsTalk Interviews
NeoGenomics (NEO) Expands Precision Oncology Focus, Is The Stock Fairly Valued? - Yahoo Finance
Is NeoGenomics’ (NEO) Community NGS Push Quietly Redefining Its Core Earnings Engine? - Yahoo Finance
NeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley Conference - MarketBeat
NeoGenomics (NEO) Stock Looks Above Fair Value On Current Sales - Simply Wall Street
A Look at NeoGenomics Inc (NEO) After 5.0% Gain -- GF Value $16. - GuruFocus
NeoGenomics (NASDAQ:NEO): What's Behind Its New High? - Kalkine Media
NeoGenomics (NASDAQ:NEO) Sets New 52-Week HighShould You Buy? - MarketBeat
Neogenomics stock hits 52-week high at 19.78 USD By Investing.com - Investing.com Australia
Neogenomics stock hits 52-week high at 19.78 USD - Investing.com
NeoGenomics Q2 2026 Earnings: EPS Beat of 51% Overshadows Revenue SilenceEarnings Trend Analysis - careplusvn.com
NeoGenomics at Morgan Stanley conference: NGS, MRD drive growth By Investing.com - Investing.com Canada
Squarepoint Ops LLC Purchases 120,342 Shares of NeoGenomics, Inc. $NEO - MarketBeat
WINTON GROUP Ltd Purchases New Position in NeoGenomics, Inc. $NEO - MarketBeat
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
(NEO) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
NEOGENOMICS, INC.COMMON STOCKGilbert Ray Cisneros, Jr. Congressional Trade on Aug. 07, 2026 - Quiver Quantitative
A Look Back at Testing & Diagnostics Services Stocks’ Q2 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack - Yahoo Finance
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
NeoGenomics, Inc. $NEO Shares Bought by First Light Asset Management LLC - MarketBeat
NeoGenomics Inc. (NEO) Key Financial Ratios – Valuation, Profitability & More - Value Research
NeoGenomics EVP Alicia Olivo Surrenders Shares for Tax Withholding Following Restricted Stock Vesting - Kalkine Media
Bank of New York Mellon Corp Takes Position in NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Business Wire
NeoGenomics Inc. (NEO) Peer Comparison – Compare with Others - Value Research
NeoGenomics Inc. (NEO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO), LeonaBio (LONA) and Solid Biosciences (SLDB) - The Globe and Mail
NeoGenomics Shares Rise After RaDaR ST Assay Gets Expanded Medicare Coverage - marketscreener.com
NeoGenomics Stock Just Turned Its First Profit, Creating an Optimal Entry Point - Yahoo Finance
NeoGenomics gains Medicare coverage for cancer MRD test By Investing.com - Investing.com Canada
NeoGenomics RaDaR ST wins expanded Medicare coverage for immunotherapy response monitoring - Bitget
NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring - Yahoo Finance
NeoGenomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
NeoGenomics (NEO) COO converts 28K stock units into common shares - Stock Titan
NeoGenomics, Inc. (NEO) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
NeoGenomics (NASDAQ:NEO) Healthcare Innovation Gains Attention - Kalkine Media
NeoGenomics (NASDAQ:NEO) Reaches New 12-Month HighHere's Why - MarketBeat
Neogenomics stock hits 52-week high at 16.93 USD By Investing.com - Investing.com Nigeria
Neogenomics stock hits 52-week high at 16.93 USD - Investing.com
NeoGenomics, Inc. Revenue Breakdown – NASDAQ:NEO - TradingView
NeoGenomics (NEO) Advances 1.44% to $16.17 as Buyers Hold Above Key SupportPercent Above MA - vinanet.vn
NeoGenomics (NASDAQ:NEO) Enters A New Growth Spotlight - Kalkine Media
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
0.97%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):